Reported Aug 31, 2016 · Terminated

Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada…

Teva North America

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Teva North America · 425 Privet Rd · Horsham, PA · 19044-1220

Is this the product you have?

  • Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only
  • Manufactured In Canada byTeva Canada Limited, Toronto, Canada, NDC 0093-4161-76
Lot codes and dates
    • Lot # 35434158A
    • Exp 6/17
Amount recalled
53,328 bottles

Where it was sold

  • Nationwide

Why it was recalled

Superpotent drug: Out of specification test result for assay during stability testing.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teva North America recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 7, 2017 · Data as of Sep 19, 6:28 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.